Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
An organ-on-a-chip is a device that combines micro-manufacturing and tissue engineering to replicate the critical physiological environment and functions of the human organs. Therefore, it can be used to predict drug responses and environmental effects on organs. Microfluidic technology can control micro-scale reagents with high precision. Hence, microfluidics have been widely applied in organ-on-chip systems to mimic specific organ or multiple organs in vivo. These models integrated with various sensors show great potential in simulating the human environment. In this review, we mainly introduce the typical structures and recent research achievements of several organ-on-a-chip platforms. We also discuss innovations in models applied to the fields of pharmacokinetics/pharmacodynamics, nano-medicine, continuous dynamic monitoring in disease modeling, and their further applications in other fields.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 3×
“in 2010 attracted great attention [8].”
BackgroundMethodInfluentialThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
The neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
A soft, wearable microfluidic device for the capture, storage, and colorimetric sensing of sweat
Koh, A., Kang, D., Xue, Y., Lee, S., Pielak, R. M., Kim, J., Hwang, T., Min, S., Banks, A., Bastien, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2593 · Cited by 1,308
Park, S. E., Georgescu, A., & Huh, D. (2019) · Science · doi:10.1126/science.aaw7894 · Cited by 847
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612906114 · Cited by 833
Research works printed but not linked: 93
- Mitchell, 2001, Microfluidics—Downsizing large-scale biology, Nat. Biotechnol., 19, 717, 10.1038/90754 · DOI · Paper page
- Mark, 2010, Microfluidic lab-on-a-chip platforms: Requirements, characteristics and applications, Chem. Soc. Rev., 39, 1153, 10.1039/b820557b · DOI · Paper page
- Kartalov, 2007, Experimentally validated quantitative linear model for the device physics of elastomeric microfluidic valves, J. Appl. Phys., 101, 64505, 10.1063/1.2511688 · doi:10.1063/1.2511688
- Thorsen, 2004, Microfluidic tools for high-throughput screening, Biotechniques, 36, 197, 10.2144/04362TE01 · DOI
- Manz, 1992, Planar chips technology for miniaturization and integration of separation techniques into monitoring systems, J. Chromatogr. A, 593, 253, 10.1016/0021-9673(92)80293-4 · DOI · Paper page
- Thorsen, 2002, Microfluidic large-scale integration, Science, 298, 580, 10.1126/science.1076996 · DOI · Paper page
- Hyejin, 2003, Creating, transporting, cutting, and merging liquid droplets by electrowetting-based actuation for digital microfluidic circuits, J. Microelectromech. Syst., 12, 70, 10.1109/JMEMS.2002.807467 · DOI · Paper page
- Zhang, 2017, Point-of-care-testing of nucleic acids by microfluidics, TrAC Trends Anal. Chem., 94, 106, 10.1016/j.trac.2017.07.013 · DOI · Paper page
- Shehab, 2016, US Emergency Department Visits for Outpatient Adverse Drug Events, 2013–2014, JAMA, 316, 2115, 10.1001/jama.2016.16201 · DOI · Paper page
- McLean, 2018, Powering ex vivo tissue models in microfluidic systems, Lab Chip, 18, 1399, 10.1039/C8LC00241J · DOI
- McConnell, 1992, The cytosensor microphysiometer: Biological applications of silicon technology, Science, 257, 1906, 10.1126/science.1329199 · DOI · Paper page
- Park, 2003, Integration of cell culture and microfabrication technology, Biotechnol. Prog., 19, 243, 10.1021/bp020143k · DOI · Paper page
- Esch, 2011, The role of body-on-a-chip devices in drug and toxicity studies, Annu. Rev. Biomed. Eng., 13, 55, 10.1146/annurev-bioeng-071910-124629 · DOI · Paper page
- Nakao, 2011, Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device, Biomicrofluidics, 5, 22212, 10.1063/1.3580753 · DOI · Paper page
- Jang, 2013, Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment, Integr. Biol., 5, 1119, 10.1039/c3ib40049b · DOI · Paper page
- An, 2016, A Laminated Microfluidic Device for Comprehensive Preclinical Testing in the Drug ADME Process, Sci. Rep., 6, 25022, 10.1038/srep25022 · DOI
- Franco, 2012, Tissue engineering: Blood vessels on a chip, Nature, 488, 465, 10.1038/488465a · DOI
- Atac, 2013, Skin and hair on-a-chip: In vitro skin models versus ex vivo tissue maintenance with dynamic perfusion, Lab Chip, 13, 3555, 10.1039/c3lc50227a · DOI · Paper page
- Torisawa, 2014, Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro, Nat. Methods, 11, 663, 10.1038/nmeth.2938 · DOI · Paper page
- Griep, 2013, BBB on chip: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function, Biomed. Microdevices, 15, 145, 10.1007/s10544-012-9699-7 · DOI · Paper page
- Lee, 2019, Advances in dynamic microphysiological organ-on-a-chip: Design principle and its biomedical application, J. Ind. Eng. Chem., 71, 65, 10.1016/j.jiec.2018.11.041 · DOI
- Nelson, 2020, A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases, Lab Chip, 20, 3601, 10.1039/D0LC00644K · DOI
- Zhang, 2018, A 3D human lung-on-a-chip model for nanotoxicity testing, Toxicol. Res., 7, 1048, 10.1039/C8TX00156A · DOI · Paper page
- Zamprogno, 2021, Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane, Commun. Biol., 4, 168, 10.1038/s42003-021-01695-0 · DOI · Paper page
- Gard, 2021, High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro, Sci. Rep., 11, 14961, 10.1038/s41598-021-94095-7 · DOI
- Toh, 2009, A microfluidic 3D hepatocyte chip for drug toxicity testing, Lab Chip, 9, 2026, 10.1039/b900912d · DOI · Paper page
- Jing, 2020, Establishment and Application of Peristaltic Human Gut-Vessel Microsystem for Studying Host-Microbial Interaction, Front. Bioeng. Biotechnol., 8, 272, 10.3389/fbioe.2020.00272 · DOI
- Wang, 2017, Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening, Biotechnol. Bioeng., 114, 184, 10.1002/bit.26045 · DOI · Paper page
- Wevers, 2018, A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport, Fluids Barriers CNS, 15, 23, 10.1186/s12987-018-0108-3 · DOI · Paper page
- Papademetriou, I., Vedula, E., Charest, J., and Porter, T. (2018). Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier. PLoS ONE, 13. · DOI
- Marsano, 2016, Beating heart on a chip: A novel microfluidic platform to generate functional 3D cardiac microtissues, Lab Chip, 16, 599, 10.1039/C5LC01356A · DOI · Paper page
- Zhang, 2016, Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip, Biomaterials, 110, 45, 10.1016/j.biomaterials.2016.09.003 · DOI · Paper page
- Faulkner-Jones, A., Zamora, V., Hortigon-Vinagre, M.P., Wang, W., Ardron, M., Smith, G.L., and Shu, W. (2022). A Bioprinted Heart-on-a-Chip with Human Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Evaluation. Bioengineering, 9. · DOI
- Jayne, 2021, Direct laser writing for cardiac tissue engineering: A microfluidic heart on a chip with integrated transducers, Lab Chip, 21, 1724, 10.1039/D0LC01078B · DOI
- Jeon, 2020, Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip, J. Ind. Eng. Chem., 82, 71, 10.1016/j.jiec.2019.09.044 · DOI · Paper page
- Kim, K., Jeon, H.M., Choi, K.C., and Sung, G.Y. (2020). Testing the Effectiveness of Curcuma longa Leaf Extract on a Skin Equivalent Using a Pumpless Skin-on-a-Chip Model. Int. J. Mol. Sci., 21. · DOI
- Zhang, 2021, Construction of a high fidelity epidermis-on-a-chip for scalable in vitro irritation evaluation, Lab Chip, 21, 3804, 10.1039/D1LC00099C · DOI · Paper page
- Llenas, M., Paoli, R., Feiner-Gracia, N., Albertazzi, L., Samitier, J., and Caballero, D. (2021). Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors. Bioengineering, 8. · DOI
- Abudupataer, 2019, Bioprinting a 3D vascular construct for engineering a vessel-on-a-chip, Biomed. Microdevices, 22, 10, 10.1007/s10544-019-0460-3 · DOI
- Zhou, 2021, Fabrication of PDMS microfluidic devices using nanoclay-reinforced Pluronic F-127 as a sacrificial ink, Biomed. Mater., 16, 045005, 10.1088/1748-605X/abe55e · DOI
- Tian, 2020, A Novel Tissue-Based Liver-Kidney-on-a-Chip Can Mimic Liver Tropism of Extracellular Vesicles Derived from Breast Cancer Cells, Biotechnol. J., 15, e1900107, 10.1002/biot.201900107 · DOI
- Selahi, 2021, Lymphangion-chip: A microphysiological system which supports co-culture and bidirectional signaling of lymphatic endothelial and muscle cells, Lab Chip, 22, 121, 10.1039/D1LC00720C · DOI
- Zhou, 2018, Extracellular matrix in lung development, homeostasis and disease, Matrix Biol., 73, 77, 10.1016/j.matbio.2018.03.005 · DOI · Paper page
- Xu, 2020, Assessment of Air Pollutant PM2.5 Pulmonary Exposure Using a 3D Lung-on-Chip Model, ACS Biomater. Sci. Eng., 6, 3081, 10.1021/acsbiomaterials.0c00221 · DOI
- Moradi, 2020, Microfluidic organ-on-a-chip models of human liver tissue, Acta Biomater., 116, 67, 10.1016/j.actbio.2020.08.041 · DOI · Paper page
- Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
- Jeon, 2021, In vitro hepatic steatosis model based on gut-liver-on-a-chip, Biotechnol. Prog., 37, e3121, 10.1002/btpr.3121 · DOI
- Chen, 2017, Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk, Biotechnol. Bioeng., 114, 2648, 10.1002/bit.26370 · DOI · Paper page
- Lee, 2018, Gut–liver on a chip toward an in vitro model of hepatic steatosis, Biotechnol. Bioeng., 115, 2817, 10.1002/bit.26793 · DOI
- 2015, The human gut resistome, Philos. Trans. R. Soc. Lond. B Biol. Sci., 370, 20140087, 10.1098/rstb.2014.0087 · DOI · Paper page
- Compare, 2012, Gut--liver axis: The impact of gut microbiota on non alcoholic fatty liver disease, Nutr. Metab. Cardiovasc. Dis., 22, 471, 10.1016/j.numecd.2012.02.007 · DOI · Paper page
- Sung, 2011, Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model, Lab Chip, 11, 389, 10.1039/C0LC00273A · DOI · Paper page
- Benson, 2013, Impedance-based cell monitoring: Barrier properties and beyond, Fluids Barriers CNS, 10, 5, 10.1186/2045-8118-10-5 · DOI · Paper page
- Thuenauer, 2014, Microfluidic approaches for epithelial cell layer culture and characterisation, Analyst, 139, 3206, 10.1039/C4AN00056K · DOI
- Henry, 2019, Non-invasive sensing of transepithelial barrier function and tissue differentiation in organs-on-chips using impedance spectroscopy, Lab Chip, 19, 452, 10.1039/C8LC00129D · DOI · Paper page
- Cardoso, 2010, Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches, Brain Res. Rev., 64, 328, 10.1016/j.brainresrev.2010.05.003 · DOI · Paper page
- Kim, 2015, Collagen-based brain microvasculature model in vitro using three-dimensional printed template, Biomicrofluidics, 9, 024115, 10.1063/1.4917508 · DOI · Paper page
- Jeong, 2018, A Three-Dimensional Arrayed Microfluidic Blood-Brain Barrier Model With Integrated Electrical Sensor Array, IEEE Trans. Biomed. Eng., 65, 431, 10.1109/TBME.2017.2773463 · DOI
- Park, 2019, Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies, Nat. Commun., 10, 2621, 10.1038/s41467-019-10588-0 · DOI · Paper page
- Hirose, 2019, Evidence for hormonal control of heart regenerative capacity during endothermy acquisition, Science, 364, 184, 10.1126/science.aar2038 · DOI · Paper page
- Visone, R., Gilardi, M., Marsano, A., Rasponi, M., Bersini, S., and Moretti, M. (2016). Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering. Molecules, 21. · DOI
- Grosberg, 2011, Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip, Lab Chip, 11, 4165, 10.1039/c1lc20557a · DOI · Paper page
- Agarwal, 2013, Microfluidic heart on a chip for higher throughput pharmacological studies, Lab Chip, 13, 3599, 10.1039/c3lc50350j · DOI · Paper page
- Colosi, 2016, Microfluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low-Viscosity Bioink, Adv. Mater., 28, 677, 10.1002/adma.201503310 · DOI · Paper page
- Sun, L., Chen, Z., Xu, D., and Zhao, Y. (2022). Electroconductive and Anisotropic Structural Color Hydrogels for Visual Heart-on-a-Chip Construction. Adv. Sci., e2105777. · DOI
- Gotz, 2012, Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: Activating enzymes (Phase I), Exp. Derm., 21, 358, 10.1111/j.1600-0625.2012.01486.x · DOI
- He, 2021, A Colorimetric Dermal Tattoo Biosensor Fabricated by Microneedle Patch for Multiplexed Detection of Health-Related Biomarkers, Adv. Sci., 8, e2103030, 10.1002/advs.202103030 · DOI · Paper page
- Lukacs, B., Bajza, A., Kocsis, D., Csorba, A., Antal, I., Ivan, K., Laki, A.J., and Erdo, F. (2019). Skin-on-a-Chip Device for Ex Vivo Monitoring of Transdermal Delivery of Drugs-Design, Fabrication, and Testing. Pharmaceutics, 11. · DOI
- Autier, 2008, Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor, Arch. Derm., 144, 886, 10.1001/archderm.144.7.886 · doi:10.1001/archderm.144.7.886
- Lee, 2021, Bone Microvasculature: Stimulus for Tissue Function and Regeneration, Tissue Eng. Part B Rev., 27, 313, 10.1089/ten.teb.2020.0154 · DOI
- Asaumi, 2021, Photolithography-free Vessel-on-a-chip to Simulate Tumor Cell Extravasation, Sens. Mater., 33, 241
- Salipante, 2021, Blood vessel-on-a-chip examines the biomechanics of microvasculature, Soft Matter, 18, 117, 10.1039/D1SM01312B · DOI
- Basile, 2012, Pathophysiology of acute kidney injury, Compr. Physiol., 2, 1303, 10.1002/cphy.c110041 · DOI · Paper page
- Xiao, 2017, A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle, Nat. Commun., 8, 14584, 10.1038/ncomms14584 · DOI · Paper page
- Novak, 2020, Robotic fluidic coupling and interrogation of multiple vascularized organ chips, Nat. Biomed. Eng., 4, 407, 10.1038/s41551-019-0497-x · DOI · Paper page
- Herland, 2020, Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips, Nat. Biomed. Eng., 4, 421, 10.1038/s41551-019-0498-9 · DOI · Paper page
- Baert, 2020, A multi-organ-chip co-culture of liver and testis equivalents: A first step toward a systemic male reprotoxicity model, Hum. Reprod., 35, 1029, 10.1093/humrep/deaa057 · DOI
- Maschmeyer, 2015, Chip-based human liver-intestine and liver-skin co-cultures—A first step toward systemic repeated dose substance testing in vitro, Eur. J. Pharm. Biopharm., 95, 77, 10.1016/j.ejpb.2015.03.002 · DOI · Paper page
- Rowland, 2011, Physiologically-based pharmacokinetics in drug development and regulatory science, Annu. Rev. Pharm. Toxicol., 51, 45, 10.1146/annurev-pharmtox-010510-100540 · DOI · Paper page
- Chi, 2020, High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics, Adv. Healthc. Mater., 9, e2000880, 10.1002/adhm.202000880 · DOI
- Liu, 2020, Investigation of absorption, metabolism and toxicity of ginsenosides compound K based on human organ chips, Int. J. Pharm., 587, 119669, 10.1016/j.ijpharm.2020.119669 · DOI · Paper page
- Shinha, 2020, A pharmacokinetic-pharmacodynamic model based on multi-organ-on-a-chip for drug-drug interaction studies, Biomicrofluidics, 14, 044108, 10.1063/5.0011545 · DOI · Paper page
- Skardal, 2020, Drug compound screening in single and integrated multi-organoid body-on-a-chip systems, Biofabrication, 12, 025017, 10.1088/1758-5090/ab6d36 · DOI · Paper page
- Gokaltun, 2017, Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology, Technology, 5, 1, 10.1142/S2339547817300013 · DOI · Paper page
- Wagner, 2006, The emerging nanomedicine landscape, Nat. Biotechnol., 24, 1211, 10.1038/nbt1006-1211 · DOI · Paper page
- Chen, 2021, Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine, Bioact. Mater., 6, 1012
- Lu, 2021, Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity, Bioact. Mater., 6, 2801
- Davila, 2021, Microvessel-on-Chip Fabrication for the In Vitro Modeling of Nanomedicine Transport, ACS Omega, 6, 25109, 10.1021/acsomega.1c00735 · DOI
- Lee, 2021, 3D Microfluidic Platform and Tumor Vascular Mapping for Evaluating Anti-Angiogenic RNAi-Based Nanomedicine, ACS Nano, 15, 338, 10.1021/acsnano.0c05110 · DOI
- Egorov, 2021, Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems, Drug Deliv. Transl. Res., 11, 345, 10.1007/s13346-021-00929-2 · DOI
- Aleman, 2021, Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices, Nat. Protoc., 16, 2564, 10.1038/s41596-021-00511-7 · DOI · Paper page
- Shang, 2019, Chip modularity enables molecular information access from organ-on-chip devices with quality control, Sens. Actuators B Chem., 295, 30, 10.1016/j.snb.2019.05.030 · DOI
- Farooqi, 2020, Real-time physiological sensor-based liver-on-chip device for monitoring drug toxicity, J. Micromech. Microeng., 30, 115013, 10.1088/1361-6439/ababf4 · DOI
Cited by
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
Miller, D. M., Archer, S. L., & Dunham-Snary, K. J. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1585508 · Cited by 11
Hecking, J., Cano-Jorge, M., Passier, R., & Rivera-Arbeláez, J. M. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1719533
“These intricate systems are known for their ability to modulate and precisely control both biochemical cues and physiological or pathophysiological parameters (Liu et al., 2023; Li et al., 2022).”
Metadata
- Authors
- Li, Z., Hui, J., Yang, P., & Mao, H.
- Venue
- Biosensors
- Publisher
- MDPI AG
- Published
- 2022-05-27
- Volume
- 12
- Issue
- 6
- Pages
- 370
- ISSN
- 2079-6374 (ISSN-L)
- OpenAlex
- W4281999480
- Cited by
- 120
- References
- 34
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Key Research and Development Program, China (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
- National Science Foundation, China (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
- Shanghai Sailing Program (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
- Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
- China Postdoctoral Science Foundation (2018YFA0108202, 61971410, 62001458, 20YF1457100, 20DZ2254400, 2020000246)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development. https://app.cochat.ai/papers/10.3390/bios12060370
- The paper
- Li, Z., Hui, J., Yang, P., & Mao, H. (2022). Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development. Biosensors. https://doi.org/10.3390/bios12060370
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.